A considerable legal battle has emerged involving an entity backed by Cboe and Citadel Securities, which has instituted a lawsuit against the Commodity Futures Trading Commission (CFTC) to impede the introduction of stock PERPs (perpetual futures) on U.S. exchanges. This legal action coincided with the CFTC’s approval of the product on November 3, 2026, a move that could significantly influence the $5 billion daily market for hyperliquid trading available to American investors.
The significance of the approval is underscored by CFTC Chairman Michael Selig’s remarks, asserting that Americans should not be relegated to trading on offshore, frequently unregulated exchanges for perpetual futures on individual stocks.
🇺🇸 Group backed by CBOE and Citadel Securities sues CFTC to block perpetual futures trading in U.S. stocks, same day CFTC approves lawsuit pic.twitter.com/38PNXGcM5f
— Wolf of All Street (@scottmelker) November 3, 2026
In the past 24 hours alone, trade.xyz, which operates on the Hyperliquid platform, reported a trading volume of $4.99 billion across stocks, indexes, and commodities, indicating the platform’s substantial impact on trading dynamics. Meanwhile, ICE, the parent company of the NYSE, has recently pledged to offer these markets to U.S. traders through a CFTC-regulated exchange
CBOE and Citadel’s Proposition: Understanding the Lawsuit
The Capital Markets Alliance, consisting of firms like Cboe, Citadel Securities, and the Healthy Markets Association, is the party behind the lawsuit filed in Manhattan federal court. This group contends that the contracts in question should be classified as security-based swaps, which would place them under the purview of the SEC and restrict retail investor access.
Specifically, the alliance is requesting that the court:
- Invalidate the CFTC’s approval, citing it was granted without a proper vote under Rule 40.3.
- Recognize these contracts as security-based swap agreements.
- Halt trading while the litigation unfolds.
Cboe CEO Craig Donahue emphasized, “But this issue is about investor protection and the rule of law in securities transactions.” In response, CFTC representatives stated that the integrity of markets should not be compromised by litigation that seeks to impede innovation.
Several exchanges are closely monitoring the case, including Kalsi, Coinbase Derivatives, Bitnomial, and Crypto.com’s North American derivatives exchanges. Notably, CME Group has previously taken legal action against the CFTC regarding Kalsi’s Bitcoin Perpetual contract, which had gained approval in May.
Trade Trends on Hyperliquid
Hyperliquid has shown impressive trading capabilities, achieving $7.14 billion in crypto perpetual trading volumes within the same 24-hour timeframe. This indicates that trade.xyz constitutes roughly 41% of all trades conducted on-chain during this period.
Recent data reflects that individual stocks lead trading activities on the platform, with the following highlights from popular assets:
- S&P 500: $571 million in trading volume, up to 50x leverage
- SK Hynix: $375 million, surpassing all U.S. stock volumes
- Nvidia: $257 million at 20x leverage
- SanDisk and SpaceX: $247 million and $198 million, respectively
Originally established in October 2025, trade.xyz was the first marketplace built on Hyperliquid’s HIP-3 system, facilitating external teams to list their own contracts. Currently, it manages about 98% of HIP-3’s trading volume, aggregating a total transaction value of $650 billion.
Implications of the Legal Action on Hyperliquid
While the current lawsuit does not directly affect Hyperliquid’s trading operations, the outcomes have significant implications for the company’s American expansion. The lawsuit ultimately revolves around the ability of U.S. exchanges to compete for market share. The possibilities bifurcate:
- If the Alliance prevails, the SEC will oversee the perpetual contracts, prohibiting them from retail distribution and sustaining the offshore trading environment.
- Should the CFTC succeed, U.S. exchanges like Coinbase and Kalsi could list shares in perpetuity, thereby enhancing their competitive edge over Hyperliquid’s offshore offerings.
The CFTC’s approval process for ICE’s exchange remains pending, and a critical early decision from the court regarding a potential trading freeze will determine the trajectory of U.S. listings.
Market Insights: HYPE Price Analysis
HYPE, Hyperliquid’s token, has seen fluctuations recently, climbing to $97.74 on October 29, before retracing to a current value of $85.93. The price analysis indicates key levels to monitor:
- Rebound potential: A daily close above $89.99 (October 30th) could signify a recovery.
- Resistance: Challenges may arise at $97.74, which is just below its historical high of $97.96.
- Support: The price should maintain above $81.01 to avoid further declines.
This situation highlights the ongoing struggle to define market access rights in the ever-evolving landscape of stock trading, particularly concerning who has the authority to sell stocks to American investors. Currently, Hyperliquid avails its trading services to non-U.S. users, achieving $5 billion in daily trading volume.
Disclaimer: Coinspeaker is committed to providing fair and transparent information. This article aims to deliver accurate insights but should not be construed as financial advice. Market conditions can shift rapidly; please verify facts independently and consult a financial advisor before making investment decisions.
